[go: up one dir, main page]

BR9504400A - Composiçao farmacêutica sólida e processo para a preparaçao da mesma - Google Patents

Composiçao farmacêutica sólida e processo para a preparaçao da mesma

Info

Publication number
BR9504400A
BR9504400A BR9504400A BR9504400A BR9504400A BR 9504400 A BR9504400 A BR 9504400A BR 9504400 A BR9504400 A BR 9504400A BR 9504400 A BR9504400 A BR 9504400A BR 9504400 A BR9504400 A BR 9504400A
Authority
BR
Brazil
Prior art keywords
water
pharmaceutical composition
solid pharmaceutical
preparing
oil
Prior art date
Application number
BR9504400A
Other languages
English (en)
Inventor
Haan Pieter De
Hendrika Gerardi Poels-Janssen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR9504400A publication Critical patent/BR9504400A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9504400A 1994-10-17 1995-10-13 Composiçao farmacêutica sólida e processo para a preparaçao da mesma BR9504400A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94203017 1994-10-17

Publications (1)

Publication Number Publication Date
BR9504400A true BR9504400A (pt) 1997-05-27

Family

ID=8217284

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9504400A BR9504400A (pt) 1994-10-17 1995-10-13 Composiçao farmacêutica sólida e processo para a preparaçao da mesma

Country Status (19)

Country Link
US (1) US6187339B1 (pt)
EP (1) EP0707848B1 (pt)
JP (1) JPH08268914A (pt)
KR (1) KR100388932B1 (pt)
CN (1) CN1112185C (pt)
AT (1) ATE211647T1 (pt)
AU (1) AU688581B2 (pt)
BR (1) BR9504400A (pt)
CA (1) CA2159419C (pt)
DE (1) DE69524917T2 (pt)
DK (1) DK0707848T3 (pt)
ES (1) ES2171498T3 (pt)
FI (1) FI117121B (pt)
HU (1) HU221427B (pt)
IL (1) IL115445A (pt)
MX (1) MX9504252A (pt)
PT (1) PT707848E (pt)
RU (1) RU2152802C2 (pt)
TR (1) TR199501246A2 (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
IL123984A (en) 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
EP0955048A1 (en) * 1998-03-12 1999-11-10 Akzo Nobel N.V. Making dosage units using low shear granulation
IL128818A0 (en) * 1998-03-12 2000-01-31 Akzo Nobel Nv Making dosage units using low shear granulation
RU2220975C2 (ru) * 1998-10-16 2004-01-10 Акцо Нобель Н.В. КОМПОЗИЦИЯ С ВЫСОКОЙ СТЕПЕНЬЮ ЧИСТОТЫ, СОДЕРЖАЩАЯ (7α,17α)-17-ГИДРОКСИ-7-МЕТИЛ-19-НОР-17-ПРЕГН-5(10)-ЕН-20-ИН-3-ОН, СПОСОБ ЕЕ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКИЕ СТАНДАРТНЫЕ ЛЕКАРСТВЕННЫЕ ФОРМЫ
US6756366B1 (en) * 1999-04-06 2004-06-29 Akzo Nobel N.V. Orally active androgens
US6855333B1 (en) 2000-10-03 2005-02-15 Mutual Pharmaceutical Co., Inc. Stabilization of solid thyroid drug formulations
US6979462B1 (en) * 2000-10-03 2005-12-27 Mutual Pharmaceutical Co., Inc. Stabilization of solid drug formulations
KR20040100835A (ko) 2001-02-15 2004-12-02 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법
FR2824477B1 (fr) * 2001-05-09 2005-09-09 Ethypharm Lab Prod Ethiques Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US6933380B2 (en) 2001-10-19 2005-08-23 Yung-Zip Chemical Ind. Co., Ltd. Excipients containing low residual solvent and method for producing the same
DE10159120B4 (de) * 2001-12-01 2006-08-17 Lts Lohmann Therapie-Systeme Ag Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
IS6633A (is) * 2002-11-22 2004-05-23 Omega Farma Ehf. Samsetningar af fínasteríð töflum
JP4737754B2 (ja) 2003-05-30 2011-08-03 旭化成ケミカルズ株式会社 セルロース粉末
HUE031092T2 (en) * 2003-07-17 2017-07-28 Banner Life Sciences Llc Controlled release preparations
DE102004059880A1 (de) * 2004-12-10 2006-06-14 Grünenthal GmbH Stabiles, hormonhaltiges (Zwischen-)Produkt
ES2639130T3 (es) * 2007-06-06 2017-10-25 Basf Se Formulación farmacéutica para la fabricación de comprimidos de rápida desintegración
JP2010529073A (ja) * 2007-06-06 2010-08-26 ビーエーエスエフ ソシエタス・ヨーロピア チュアブル錠及びトローチ剤製造のための医薬製剤
CZ300465B6 (cs) * 2007-07-25 2009-05-27 Zentiva, A. S. Zpusob výroby komprimované farmaceutické formulace s obsahem tibolonu
DE102009012788A1 (de) * 2009-03-13 2010-09-30 J. Rettenmaier & Söhne Gmbh + Co. Kg Verpressbares Tablettenmaterial mit ölhaltigem Wirkstoff, Tablette sowie Verfahren und Vorrichtung zu deren Herstellung
HUP0900698A2 (en) 2009-11-06 2011-06-28 Richter Gedeon Nyrt Pharmaceutical compositions of enhanced stability containing drospirenone and ethynyl estradiol and process for their preparation
DE102011010437A1 (de) * 2011-02-04 2012-08-09 J. Rettenmaier & Söhne Gmbh + Co. Kg Tablettierhilfsmittel
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10206932B2 (en) 2014-05-22 2019-02-19 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2195893A (en) * 1938-07-28 1940-04-02 Nellie C Mcgann Two-part support clamp
US2965541A (en) * 1959-06-22 1960-12-20 Upjohn Co 17alpha-acetoxyprogesterone compositions for oral use and methods of using same
US3568828A (en) * 1967-03-01 1971-03-09 Squibb & Sons Inc Modified sequential oral contraceptive
NL7506407A (nl) * 1975-05-30 1976-12-02 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam far- maceutisch preparaat.
JPS57142911A (en) * 1981-02-28 1982-09-03 Furointo Sangyo Kk Absorption-improving agent
JPS57165392A (en) * 1981-04-06 1982-10-12 Toyo Jozo Co Ltd Long-acting cephalexin tablet
US4544554A (en) * 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
FR2571045B1 (fr) * 1984-10-03 1987-12-11 Roquette Freres Mannitol granulaire directement compressible et son procede de fabrication
EP0330284B1 (en) * 1988-02-25 1994-07-27 Yamanouchi Europe B.V. Process for the preparation of a pharmaceutical granulate
US5169645A (en) * 1989-10-31 1992-12-08 Duquesne University Of The Holy Ghost Directly compressible granules having improved flow properties
EP0487774B1 (en) * 1990-11-29 1994-10-26 Wei Ming Pharmaceutical Mfg. Co. Ltd. A direct tabletting auxiliary
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) * 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5179122A (en) * 1991-02-11 1993-01-12 Eastman Kodak Company Nutritional supplement containing vitamin e
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
JPH0597672A (ja) * 1991-10-08 1993-04-20 Terumo Corp アミド誘導体含有固形製剤およびその製造方法
IT1256386B (it) * 1992-11-13 1995-12-04 Luigi Boltri Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
DE69431662T2 (de) * 1993-09-03 2003-09-18 Smithkline Beecham Corp., King Of Prussia Stabilisierte tablettenformulierung
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
US6057139A (en) * 1995-06-29 2000-05-02 Mcneil-Ppc, Inc. Preblend of microcrystalline cellulose and lactase for making tablets
US5801220A (en) * 1995-11-01 1998-09-01 E.R. Squibb & Sons, Inc. Rapidly disintegrating thickening composition
US6096337A (en) * 1996-06-10 2000-08-01 Spireas; Spiridon Liquisolid systems and methods of preparing same
US5800834A (en) * 1996-06-10 1998-09-01 Spireas; Spiridon Liquisolid systems and methods of preparing same
DE19628617A1 (de) * 1996-07-16 1998-01-22 Basf Ag Direkttablettierhilfsmittel

Also Published As

Publication number Publication date
IL115445A0 (en) 1995-12-31
IL115445A (en) 1999-08-17
FI954905A0 (fi) 1995-10-16
CA2159419A1 (en) 1996-04-18
HU221427B (en) 2002-10-28
EP0707848A1 (en) 1996-04-24
ATE211647T1 (de) 2002-01-15
FI954905L (fi) 1996-04-18
FI117121B (fi) 2006-06-30
US6187339B1 (en) 2001-02-13
HK1001886A1 (en) 1998-07-17
DE69524917T2 (de) 2002-08-29
KR100388932B1 (ko) 2003-09-19
PT707848E (pt) 2002-06-28
DK0707848T3 (da) 2002-04-15
DE69524917D1 (de) 2002-02-14
TR199501246A2 (tr) 1996-06-21
AU688581B2 (en) 1998-03-12
AU3426795A (en) 1996-05-02
CN1130064A (zh) 1996-09-04
CN1112185C (zh) 2003-06-25
ES2171498T3 (es) 2002-09-16
KR960013373A (ko) 1996-05-22
EP0707848B1 (en) 2002-01-09
MX9504252A (es) 1997-01-31
JPH08268914A (ja) 1996-10-15
CA2159419C (en) 2006-07-04
RU2152802C2 (ru) 2000-07-20
HUT75247A (en) 1997-05-28
HU9502985D0 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
BR9504400A (pt) Composiçao farmacêutica sólida e processo para a preparaçao da mesma
DE69032848D1 (de) Dosierungsmittel und dessen Verwendung
BR9007073A (pt) Composicao agricola a base de agua
PE21891A1 (es) Sistemas excipientes para uso en composiciones cosmeticas
PT643963E (pt) Dispositivo biodegradavel para administracao de substancias activas
IL108738A0 (en) New multiple emulsions, their preparation, their use in the preparation of cosmetic compositions and these cosmetic compositions
BR9802509A (pt) Uso de um copolímero tendo estrutura sufactante ou tensoativa como agente dispersante e/ou auxiliar de moagem.
PT974350E (pt) Preparacao contendo tranilast para aplicacao externa e metedo para a sua producao
MX22877A (es) Procedimiento para la preparacion de pirimidas, producto obtenido y composicion farmaceutica que lo incluye
ATE269047T1 (de) Emulgatorfreie und bornitrid enthaltende feindisperse systeme vom typ öl-in-wasser und wasser-in-öl
BR9801463A (pt) Composição adesiva dotipo de pré-revestimento.
ES2011232A4 (es) Compuestos farmaceuticos en piroxicam en soluciones acuosas y proceso para su preparacion
ES2183172T3 (es) Procedimiento para la preparacion de microparticulas.
BR9913718A (pt) Processo e composição farmacêutica ou veterinária para inibição profilática ou terapêutica de um material ou substância tóxica em um paciente animal humano ou não-humano, e, uso de um dendrìmero aniÈnico ou catiÈnico
BR0109802A (pt) Preparações farmacêuticas e sua fabricação
ES2186207T3 (es) Metodo para preparacion de formulaciones farmaceuticas.
FR2796308B1 (fr) Composition sous forme d'emulsion eau-dans-huile et ses utilisations cosmetiques
PT1186292E (pt) Preparados solidos com estrutura multinuclear
BR9706889A (pt) Uso de extratos de ginkgo biloba para a preparação de composições farmacêuticas e processo de tratamento cosmético usando um extrato de ginkgo biloba
BR9811985A (pt) Dispositivo de dosagem
FR2653339B1 (fr) Compositions cosmetique et pharmaceutique contenant des spheres de poly beta-alanine reticulee impregnees d'une substance lipophile.
PL339851A1 (en) Aqueous preparation having fungicidal, insecticidal and bactericidal properties, method of stabilising aqueous preparations, binding agent and application thereof

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
FF Decision: intention to grant
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 16A ANUIDADE.

B24H Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)
B24F Patent annual fee: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2258 DE 15/04/2014 POR TER SIDO INDEVIDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2607 DE 22-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.